Acton Pharmaceuticals Snares $15M for Inhaled Asthma Drug | Xconomy

Links shared publicly online about this topic.

  • 1,476
    total visits

Acton Pharmaceuticals Snares $15M for Inhaled Asthma Drug | Xconomy

xconomy.com —

Acton Pharmaceuticals, the Marlborough, MA-based developer of an inhalable drug for asthma, said today it has secured $15 million in a Series A financing round

View full resource at xconomy.com

Tags: Asthma, Drug, Pharma

  • Share

Most Recently Shared on January 7, 2010 at 12:57 pm By:

wheezemd Michael Blaiss, MD

Will we now see flunisolide HFA for asthma? http://is.gd/5QZlq

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

Luke Timmerman Luke Timmerman

Advertisement